Skip to main content
  • Home
  • Specialties
    • Breast Cancer
    • Cancer Screening and Survivorship
    • Cell Therapy
    • Clinical Trials
    • Gastrointestinal Cancer
    • Genitourinary Cancer
    • Gynecologic Oncology
    • Head and Neck Cancer
    • Hematologic Oncology
    • Immunotherapy
    • Neuro-Oncology and Surgery
    • Pediatric Hematology/Oncology
    • Primary Care
    • Radiation Oncology
    • Skin Cancer
    • Surgical Oncology
    • Thoracic Cancer
    • Young Adult Malignancies
  • Resources
    • Educational Events
    • Specialized Services
    • Forms and Other Resources

Francisco Hernandez-Ilizaliturri, MD

Hematologic Oncology

Francisco Hernandez-Ilizaliturri, MD

View full profile


Related Videos

New Trial for Rare Brain Lymphoma Open at Roswell Park Video

New Trial for Rare Brain Lymphoma Open at Roswell Park

Roswell Park Comprehensive Cancer Center is one of four locations in the United States and Europe in which patients with relapsed or refractory non-Hodgkin lymphoma in their central nervous system can access a new clinical trial, led by ...

Diffuse Large B-cell Lymphoma & High-grade B-cell Lymphoma Video

Diffuse Large B-cell Lymphoma & High-grade B-cell Lymphoma

A trio of panelists, including Francisco Hernandez-Ilizaliturri from Roswell Park, Kieron Dunleavy from MedStar Georgetown University and Joanna Rhodes from Rutgers Robert Wood Johnson Medical School, discuss updates in treating DLBCL and HGBLs.

First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park Video

First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park

Chimeric antigen receptor (CAR) T-cell therapy is emerging as an effective therapeutic strategy for patients with B-cell lymphoid cancers.


Powered by BroadcastMedBROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer